{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:57:08Z","timestamp":1767650228977,"version":"3.41.2"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Massachusetts Department of Public Health"},{"name":"Boston Public Health Commission"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI042853","5T32AI052074"],"award-info":[{"award-number":["P30AI042853","5T32AI052074"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Massachusetts Department of Public Health Bureau of Substance Addiction Services"},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA044085","R25DA013582","R25DA033211"],"award-info":[{"award-number":["K23DA044085","R25DA013582","R25DA033211"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Massachusetts is one of the epicenters of the opioid epidemic and has been severely impacted by injection-related viral and bacterial infections. A recent increase in newly diagnosed human immunodeficiency virus (HIV) infections among persons who inject drugs in the state highlights the urgent need to address and bridge the overlapping epidemics of opioid use disorder (OUD) and injection-related infections. Building on an established relationship between the Massachusetts Department of Public Health and Boston Medical Center, the Infectious Diseases section has contributed to the development and implementation of a cohesive response involving ambulatory, inpatient, emergency department, and community-based services. We describe this comprehensive approach including the rapid delivery of antimicrobials for the prevention and treatment of HIV, sexually transmitted diseases, systemic infections such as endocarditis, bone and joint infections, as well as curative therapy for chronic hepatitis C virus in a manner that is accessible to patients on the addiction-recovery continuum. We also provide an overview of programs that provide access to medications for OUD, harm reduction services including overdose education, and distribution of naloxone. Finally, we outline lessons learned to inform initiatives in other settings.<\/jats:p>","DOI":"10.1093\/ofid\/ofab208","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T08:47:36Z","timestamp":1619513256000},"source":"Crossref","is-referenced-by-count":3,"title":["Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital"],"prefix":"10.1093","volume":"8","author":[{"given":"Rebecca H","family":"Burns","sequence":"first","affiliation":[{"name":"Internal Medicine Residency Program, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra M","family":"Pierre","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA"},{"name":"Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai G","family":"Marathe","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA"},{"name":"Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glorimar","family":"Ruiz-Mercado","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA"},{"name":"Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L","family":"Taylor","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA"},{"name":"Grayken Center for Addiction, Boston Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simeon D","family":"Kimmel","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA"},{"name":"Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha L","family":"Johnson","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H Dawn","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Office of HIV\/AIDS, Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5169-620X","authenticated-orcid":false,"given":"Sabrina A","family":"Assoumou","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA"},{"name":"Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"2021081516203932600_CIT0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.annepidem.2019.02.012","article-title":"Increased HIV diagnoses in West Virginia counties highly vulnerable to rapid HIV dissemination through injection drug use: a cautionary tale","volume":"34","author":"Bradley","year":"2019","journal-title":"Ann Epidemiol"},{"key":"2021081516203932600_CIT0002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.15585\/mmwr.mm6810a6","article-title":"Notes from the field: HIV diagnoses among persons who inject drugs\u2014Northeastern Massachusetts, 2015\u20132018","volume":"68","author":"Cranston","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021081516203932600_CIT0003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"N Engl J Med"},{"key":"2021081516203932600_CIT0004","doi-asserted-by":"crossref","first-page":"344","DOI":"10.15585\/mmwr.mm6815a2","article-title":"Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs\u2014Seattle, Washington, 2018","volume":"68","author":"Golden","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021081516203932600_CIT0005","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021081516203932600_CIT0006","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health"},{"key":"2021081516203932600_CIT0007","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/BRS.0000000000002819","article-title":"Recent increase in the rate of spinal infections may be related to growing substance-use disorder in the State of Washington: wide population-based analysis of the Comprehensive Hospital Abstract Reporting System (CHARS) database","volume":"44","author":"Blecher","year":"2019","journal-title":"Spine (Phila Pa 1976)"},{"key":"2021081516203932600_CIT0008","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2018.10.FOCUS18449","article-title":"The increasing frequency of intravenous drug abuse-associated spinal epidural abscesses: a case series","volume":"46","author":"DiGiorgio","year":"2019","journal-title":"Neurosurg Focus"},{"key":"2021081516203932600_CIT0009","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","article-title":"Clinical outcomes of infective endocarditis in injection drug users","volume":"73","author":"Rudasill","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2021081516203932600_CIT0010","doi-asserted-by":"crossref","first-page":"e012969","DOI":"10.1161\/JAHA.119.012969","article-title":"Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States From 2002 to 2016","volume":"8","author":"Kadri","year":"2019","journal-title":"J Am Heart Assoc"},{"author":"Infectious Diseases of Society of America. Infectious Diseases and Opioid Use Disorder (OUD):","key":"2021081516203932600_CIT0011"},{"key":"2021081516203932600_CIT0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M18-1203","article-title":"Integrating treatment at the intersection of opioid use disorder and infectious disease epidemics in medical settings: a call for action after a National Academies of Sciences, Engineering, and Medicine workshop","volume":"169","author":"Springer","year":"2018","journal-title":"Ann Intern Med"},{"key":"2021081516203932600_CIT0013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drugpo.2018.01.001","article-title":"Post opioid overdose outreach by public health and public safety agencies: exploration of emerging programs in Massachusetts","volume":"54","author":"Formica","year":"2018","journal-title":"Int J Drug Policy"},{"key":"2021081516203932600_CIT0014","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021081516203932600_CIT0015","first-page":"537","article-title":"Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002\u20132009","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"author":"Massachusetts Department of Public Health","key":"2021081516203932600_CIT0016"},{"author":"Massachusetts Department of Public Health","key":"2021081516203932600_CIT0017"},{"key":"2021081516203932600_CIT0018","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/infdis\/jiaa162","article-title":"Rapid versus laboratory-based testing for HIV and hepatitis C at a drug detoxification treatment center: a randomized trial","volume":"222","author":"Assoumou","year":"2020","journal-title":"J Infect Dis"},{"key":"2021081516203932600_CIT0019","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jiaa055","article-title":"Impact of a plan of care protocol on patient outcomes in people who inject drugs with infective endocarditis","volume":"222","author":"Cooksey","year":"2020","journal-title":"J Infect Dis"},{"key":"2021081516203932600_CIT0020","doi-asserted-by":"crossref","first-page":"ofaa074","DOI":"10.1093\/ofid\/ofaa074","article-title":"In-hospital illicit drug use and patient-directed discharge: barriers to care for patients with injection-related infections","volume":"7","author":"Eaton","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2021081516203932600_CIT0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jiaa432","article-title":"Infectious diseases and injection drug use: public health burden and response","volume":"222","author":"Levitt","year":"2020","journal-title":"J Infect Dis"},{"author":"Center","key":"2021081516203932600_CIT0022"},{"key":"2021081516203932600_CIT0023"},{"author":"Boston Medical Center","key":"2021081516203932600_CIT0024"},{"key":"2021081516203932600_CIT0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11904-018-0396-x","article-title":"Integrated models of care for individuals with opioid use disorder: how do we prevent HIV and HCV?","volume":"15","author":"Rich","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2021081516203932600_CIT0026","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1377\/hlthaff.2011.0663","article-title":"The urgency of providing comprehensive and integrated treatment for substance abusers with HIV","volume":"30","author":"Volkow","year":"2011","journal-title":"Health Aff (Millwood)"},{"author":"ClinicalTrials.gov","key":"2021081516203932600_CIT0027"},{"author":"Fukuda","key":"2021081516203932600_CIT0028"},{"key":"2021081516203932600_CIT0029","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.1177\/0033354918805987","article-title":"Implementing a data to care strategy to improve health outcomes for people with HIV: a report from the Care and Prevention in the United States Demonstration Project","volume":"133","author":"Sweeney","year":"2018","journal-title":"Public Health Rep"},{"key":"2021081516203932600_CIT0030","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s10461-016-1672-7","article-title":"Sexual risk and transmission behaviors, partnerships and settings among young adult nonmedical opioid users in New York City","volume":"21","author":"Friedman","year":"2017","journal-title":"AIDS Behav"},{"key":"2021081516203932600_CIT0031","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/apc.2013.0179","article-title":"Patient perspectives of an integrated program of medical care and substance use treatment","volume":"28","author":"Drainoni","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"2021081516203932600_CIT0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsat.2015.07.007","article-title":"Engagement and substance dependence in a primary care-based addiction treatment program for people infected with HIV and people at high-risk for HIV infection","volume":"59","author":"Walley","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"2021081516203932600_CIT0033","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Arch Intern Med"},{"key":"2021081516203932600_CIT0034","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","article-title":"Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the Massachusetts Collaborative Care Model in community health centers","volume":"60","author":"LaBelle","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"2021081516203932600_CIT0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13722-016-0070-9","article-title":"Prenatal treatment for opioid dependency: observations from a large inner-city clinic","volume":"12","author":"Saia","year":"2017","journal-title":"Addict Sci Clin Pract"},{"author":"Boston Medical Center","key":"2021081516203932600_CIT0036"},{"key":"2021081516203932600_CIT0037","first-page":"; 14:e136\u20138.","article-title":"Low barrier tele-buprenorphine in the time of COVID-19: a case report","author":"Harris","year":"2020","journal-title":"J"},{"key":"2021081516203932600_CIT0038","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13722-018-0117-1","article-title":"Emergency department screening and interventions for substance use disorders","volume":"13","author":"Hawk","year":"2018","journal-title":"Addict Sci Clin Pract"},{"key":"2021081516203932600_CIT0039","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/acem.12419","article-title":"Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population","volume":"21","author":"Merchant","year":"2014","journal-title":"Acad Emerg Med"},{"key":"2021081516203932600_CIT0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0196-0644(97)70140-9","article-title":"Project ASSERT: an ED-based intervention to increase access to primary care, preventive services, and the substance abuse treatment system","volume":"30","author":"Bernstein","year":"1997","journal-title":"Ann Emerg Med"},{"key":"2021081516203932600_CIT0041","doi-asserted-by":"crossref","first-page":"108011","DOI":"10.1016\/j.jsat.2020.108011","article-title":"Appointment wait-times and arrival for patients at a low-barrier access addiction clinic","volume":"114","author":"Roy","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"2021081516203932600_CIT0042","article-title":"Sexually","author":"Harvey","year":"2021","journal-title":"J Addict Med"},{"key":"2021081516203932600_CIT0043","doi-asserted-by":"crossref","first-page":"108011","DOI":"10.1016\/j.jsat.2020.108011","article-title":"Appointment wait-times and arrival for patients at a low-barrier access addiction clinic","volume":"114","author":"Roy","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"2021081516203932600_CIT0044","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjmed.2010.01.015","article-title":"The value of infectious diseases consultation in Staphylococcus aureus bacteremia","volume":"123","author":"Honda","year":"2010","journal-title":"Am J Med"},{"key":"2021081516203932600_CIT0045","first-page":"2018; 5:ofy194.","article-title":"Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature","author":"Suzuki","journal-title":"Open Forum Infect Dis"},{"key":"2021081516203932600_CIT0046","first-page":"; 15:20\u20136.","article-title":"Rejection of patients with opioid use disorder","author":"Kimmel","year":"2021","journal-title":"J Addict Med"},{"key":"2021081516203932600_CIT0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","article-title":"Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment","volume":"79","author":"Trowbridge","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"2021081516203932600_CIT0048","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2019.08.013","article-title":"Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study","volume":"106","author":"D\u2019Amico","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"2021081516203932600_CIT0049","doi-asserted-by":"crossref","first-page":"e000699","DOI":"10.1136\/openhrt-2017-000699","article-title":"Inception of the \u2018endocarditis team\u2019 is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a before-and-after study","volume":"4","author":"Kaura","year":"2017","journal-title":"Open Heart"},{"key":"2021081516203932600_CIT0050","doi-asserted-by":"crossref","first-page":"ofz308","DOI":"10.1093\/ofid\/ofz308","article-title":"Impact of setting up an \u201cEndocarditis Team\u201d on the management of infective endocarditis","volume":"6","author":"Ruch","year":"2019","journal-title":"Open Forum Infect Dis"},{"author":"Program BHCftH","key":"2021081516203932600_CIT0051"},{"key":"2021081516203932600_CIT0052","first-page":"110","article-title":"Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2015\u20132018","author":"Alpren","year":"2020","journal-title":"Am J Public Health"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofab208\/37408828\/ofab208.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/8\/ofab208\/39741585\/ofab208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/8\/ofab208\/39741585\/ofab208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,15]],"date-time":"2021-08-15T16:21:17Z","timestamp":1629044477000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab208\/6254919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab208","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,4,27]]},"article-number":"ofab208"}}